The risks and costs of multiple-generic substitution of topiramate von DUH, M. S, PARADIS, P. E, LATREMOUILLE-VIAU, D, GREENBERG, P. E, LEE, S. P, DURKIN, M. B, WAN, G. J, RUPNOW, M. F. T, LELORIER, J

Volltext

Minimal Important Differences in the Migraine-Specific Quality of Life Questionnaire (MSQ) Version 2.1 von Cole, JC, Lin, P, Rupnow, MFT

Volltext

A double-blind comparison of risperidone, quetiapine and placebo in patients with schizophrenia experiencing an acute exacerbation requiring hospitalization von Potkin, Steven G., Gharabawi, Georges M., Greenspan, Andrew J., Mahmoud, Ramy, Kosik-Gonzalez, Colette, Rupnow, Marcia F.T., Bossie, Cynthia A., Davidson, Michael, Burtea, Victoria, Zhu, Young, Trivedi, Jintendra K.

Volltext

Comparison of 3-Factor Prothrombin Complex Concentrate and Low-Dose Recombinant Factor VIIa for Warfarin Reversal von Chapman, Scott A, Irwin, Eric D, Abou-Karam, Nada M, Rupnow, Nichole M, Hutson, Katherine E, Vespa, Jeffrey, Roach, Robert M

Volltext

Public preferences for health states with schizophrenia and a mapping function to estimate utilities from positive and negative symptom scale scores von Lenert, Leslie A., Sturley, Ann P., Rapaport, Mark H., Chavez, Shannon, Mohr, Penny E., Rupnow, Marcia

Volltext

Quantifying the population impact of a prophylactic Helicobacter pylori vaccine von Rupnow, Marcia F.T., Shachter, Ross D., Owens, Douglas K., Parsonnet, Julie

Volltext

A dynamic transmission model for predicting trends in Helicobacter pylori and associated diseases in the United States von Rupnow, M F, Shachter, R D, Owens, D K, Parsonnet, J

Volltext

Real-world treatment patterns of antihyperglycemic agents among patients with type 2 diabetes melltus (T2dm) Initiated on canagliflozin von Chow, W, Buysman, EK, Rupnow, MF, Henk, HJ

Volltext

PDB16 - Real-world treatment patterns of antihyperglycemic agents among patients with type 2 diabetes melltus (T2dm) Initiated on canagliflozin von Chow, W, Buysman, EK, Rupnow, MF, Henk, HJ

Volltext

PNL18 DIRECT COST BURDEN OF MIGRAINE AMONG MEMBERS OF US EMPLOYER GROUPS von Hawkins, K, Rupnow, M, Wang, S

Volltext

ND1 THE INDIRECT COST BURDEN OF MIGRAINE AMONG SEVERAL LARGE U.S. EMPLOYERS von Hawkins, K, Rupnow, M, Wang, S

Volltext

Toward Improved Methods for Measurement of Utility: Automated Repair of Errors in Elicitations von Lenert, Leslie A., Sturley, Ann, Rupnow, Marcia

Volltext

P.2.074 Psychotropic polypharmacy among medicaid subjects von Rupnow, M., Markowitz, J.S., Grogg, A.

Volltext

Outcomes and Costs of Risperidone versus Olanzapine in Patients with Chronic Schizophrenia or Schizoaffective Disorders: A Markov Model von Vera-Llonch, Montserrat, Delea, Thomas E., Richardson, Erin, Rupnow, Marcia, Grogg, Amy, Oster, Gerry

Volltext

Minimal important differences in the Migraine-Specific Quality of Life Questionnaire (MSQ) version von Cole, J C, Lin, P, Rupnow, M F T

Volltext

Helicobacter pylori Vaccine Development and Use: A Cost-Effectiveness Analysis Using the Institute of Medicine Methodology von Rupnow, Marcia F.T., Owens, Douglas K., Shachter, Ross, Parsonnet, Julie

Volltext

Leap for Life: Innovative Patient Education to Optimize Outcomes Among Patients with Cardiovascular Disease von Castillo, Amy B., Currie, Kristi, Adams, Jenny L., Pollex, Sarah, Nuss, Terri D., Procious, Kevin, Rupnow, Jana M., Shaw, Toynesha

Volltext

PNL9 COST-EFFECTIVENESS OFTOPIRAMATE FOR MIGRAINE PREVENTION: A MANAGED CARE PERSPECTIVE von Brown, J, Rupnow, M, Neumann, PJ, Friedman, M, Menzin, J

Volltext

PMH7 TREATMENT AND ECONOMIC OUTCOMES IN PEDIATRIC INPATIENTS TREATED WITH ATYPICAL ANTIPSYCHOTICS von Flanders, S, Pandina, G, Rupnow, M, Jensik, S

Volltext

PNL21 PATTERNS OF TOPIRAMATE UTILIZATION AMONG MEDICAID PATIENTS: DIAGNOSIS, COMORBIDITIES AND REAL-WORLD DOSING von Poston, S, Rupnow, M, Dickson, M, Johnsrud, M, Gdovin, JM, Bramley, T, Armstrong, RB

Volltext